WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report) shares dropped 3.9% during mid-day trading on Tuesday . The company traded as low as $14.75 and last traded at $14.27. Approximately 2,607 shares were traded during trading, The stock had previously closed at $14.86.
WisdomTree BioRevolution Fund Stock Down 3.9 %
The firm has a market cap of $2.14 million, a PE ratio of 15.09 and a beta of 1.07. The business has a 50 day simple moving average of $14.74 and a two-hundred day simple moving average of $15.63.
Institutional Trading of WisdomTree BioRevolution Fund
An institutional investor recently bought a new position in WisdomTree BioRevolution Fund stock. Jane Street Group LLC bought a new position in shares of WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 13,134 shares of the company’s stock, valued at approximately $217,000. Jane Street Group LLC owned 8.76% of WisdomTree BioRevolution Fund as of its most recent SEC filing.
About WisdomTree BioRevolution Fund
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Featured Stories
- Five stocks we like better than WisdomTree BioRevolution Fund
- Election Stocks: How Elections Affect the Stock Market
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Stock Market Sectors: What Are They and How Many Are There?
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.